TREATMENT
Clinical trials for TREATMENT explained in plain language.
Never miss a new study
Get alerted when new TREATMENT trials appear
Sign up with your email to follow new studies for TREATMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made cancer vaccine shows promise in advanced tumors
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a personalized vaccine created from a patient's own immune cells (dendritic cells) that are trained to attack unique markers on their tumor. It is for people with advanced solid tumors who have not responded to standard treatments. The main goal is to check safet…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Fudan University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 22:51 UTC
-
New laser treatment could ease diabetic eye swelling
Disease control Recruiting nowThis study tests a special laser (micropulse) to treat diabetic macular edema, a condition where fluid builds up in the center of the retina and blurs vision. Researchers will enroll 50 adults with diabetes who have either new or stubborn swelling. The goal is to see if the laser…
Matched conditions: TREATMENT
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated Jun 16, 2026 22:51 UTC
-
New triple therapy shows promise for tough leukemia
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, ivosidenib, and azacitidine) in adults with a specific genetic form of acute myeloid leukemia (AML) called IDH1-mutated. The goal is to see if this triple therapy can improve remission rates and survival. About 23 partici…
Matched conditions: TREATMENT
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 16, 2026 12:55 UTC
-
New glasses may slow kids' worsening eyesight
Disease control Recruiting nowThis study tests two types of special glasses (D.S.D.O. lenses) designed to slow the progression of nearsightedness (myopia) in children aged 6 to 14. About 120 children will wear the glasses daily for one year and have regular eye checkups. The goal is to see if these lenses can…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Can a personalized approach finally help smokers kick the habit?
Disease control Recruiting nowThis study tests whether changing treatments based on how well a person responds can help smokers quit. Participants will receive free nicotine patches, lozenges, varenicline, or e-cigarettes for 12 weeks. The study involves 544 adult smokers who want to quit, with all visits don…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Ancient chinese medicine takes on early puberty: new trial tests herbs and acupuncture
Disease control Recruiting nowThis study tests whether a combination of Chinese herbs (Ziyin-Xiehuo) and intradermal acupuncture can help control idiopathic precocious puberty in girls. About 170 girls aged 7.5 or younger with early signs of puberty will receive either the treatment or a placebo. The goal is …
Matched conditions: TREATMENT
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for kids with rare bleeding disorder: antibody trial launches
Disease control Recruiting nowThis study tests a new drug called Anti-CD38 antibody in 60 children aged 6 and older with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The drug aims to raise platelet counts safely in patients who have not improved with…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New hope for kids with Hard-to-Treat ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis study tests a new drug, daratumumab, against an older one, rituximab, in children aged 6 to 17 with immune thrombocytopenia (ITP) that didn't improve with steroids. ITP causes low platelets and easy bleeding. The goal is to see which drug works better at raising platelet cou…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New combo therapy offers hope for ITP patients who failed steroids
Disease control Recruiting nowThis study tests whether adding an anti-CD38 antibody to the standard drug rituximab works better than rituximab alone for adults with immune thrombocytopenia (ITP) who did not improve or relapsed after steroid treatment. About 160 participants will receive either the combination…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
New hope for ITP patients: daratumumab takes on rituximab in head-to-head trial
Disease control Recruiting nowThis study compares two antibody drugs, daratumumab and rituximab, in 160 adults with immune thrombocytopenia (ITP) whose condition did not improve or came back after steroid treatment. The goal is to see which drug better raises platelet counts and reduces bleeding risk. Partici…
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
New acid blocker takes on stomach bug in Head-to-Head trial
Disease control Recruiting nowThis study tests whether a newer acid-blocking drug (P-CAB) works better than a standard one (PPI) when used as part of a four-drug treatment for H. pylori, a stomach infection that can cause ulcers. About 320 adults who have not been treated before will receive either the P-CAB …
Matched conditions: TREATMENT
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New hope for young hodgkin patients: drug combo aims to cut radiation need
Disease control Recruiting nowThis study tests a new treatment for children, teens, and young adults (ages 2 to 34) newly diagnosed with classical Hodgkin lymphoma. The drug brentuximab vedotin replaces two older drugs to see if it can shrink tumors faster and more completely, so fewer patients need radiation…
Matched conditions: TREATMENT
Phase: PHASE2, PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New drug cocktail aims to boost platelets in Hard-to-Treat ITP
Disease control Recruiting nowThis study tests whether combining two drugs—rituximab and daratumumab—can safely raise platelet counts in adults with immune thrombocytopenia (ITP) who did not get better with steroids. About 20 people will receive the combo and be followed for 12 weeks to see if their platelet …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
Could stem cells heal deadly skin wounds in kidney patients?
Disease control Recruiting nowThis early-stage study tests whether stem cells from the amniotic sac can help heal painful wounds in people with calciphylaxis, a rare and serious condition linked to chronic kidney disease. Nine adults aged 18-75 will receive the treatment and be monitored for wound healing and…
Matched conditions: TREATMENT
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 01, 2026 18:05 UTC
-
Teens with concussions: could a higher dose of exercise be the key to faster recovery?
Symptom relief Recruiting nowThis study looks at whether a higher amount of aerobic exercise (like brisk walking or cycling) can help teenagers recover faster from a concussion. Researchers will compare a standard exercise program to a higher-dose one, starting within two weeks of injury. The goal is to see …
Matched conditions: TREATMENT
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Teen concussion recovery: sleep program shows promise
Symptom relief Recruiting nowThis study tests a sleep health program for teens aged 10-19 who recently had a concussion. The goal is to see if better sleep helps symptoms go away faster and improves sleep quality, mood, and school engagement. Participants will be randomly assigned to the sleep program or sta…
Matched conditions: TREATMENT
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Can a nerve block cure your headache? new study investigates
Knowledge-focused Recruiting nowThis study aims to find out which patient factors influence how well a nerve block works for medication-overuse headache. Researchers will give 70 adults an ultrasound-guided injection and track their pain and medication use for one month. The goal is to better predict who will b…
Matched conditions: TREATMENT
Sponsor: Sultan 1. Murat State Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
Which surgery is better for uterine septum? new study aims to find out
Knowledge-focused Recruiting nowThis study compares two surgical techniques for removing a uterine septum, a wall of tissue inside the uterus that can cause problems. Researchers want to see if using scissors without electricity is better than using an electric tool. The study will look at surgery time, cost, c…
Matched conditions: TREATMENT
Phase: NA • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC